TrialJournal of the American Heart Association2023

Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors.

Saket Girotra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.